From February 7, 2022 to March 31, 2022, the company has repurchased 750,342 shares, representing 0.05% for CNY 7.44 million. With this, the company has completed the repurchase of 750,342 shares, representing 0.05% for CNY 7.44 million under the buyback announced on February 8, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.87 CNY | -1.00% |
|
-3.17% | -13.21% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.21% | 2.04B | |
+1.43% | 94.45B | |
-0.66% | 38.9B | |
-13.57% | 32.56B | |
+71.55% | 28.34B | |
-12.73% | 15.98B | |
-2.15% | 13.82B | |
-13.59% | 11.34B | |
+158.88% | 9.81B | |
-52.04% | 9.67B |
- Stock Market
- Equities
- 300009 Stock
- News Anhui Anke Biotechnology (Group) Co., Ltd.
- Tranche Update on Anhui Anke Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 8, 2022.